Rules for Eligibility
Rules for Eligibility
1. INELIGIBILITY FOR APPLYING FOR OR RECEIVING GRANTS FROM THE NOVO NORDISK FOUNDATION
The following shall be considered ineligible to apply for or receive grants from the Novo Nordisk Foundation:
a) Employees of the Novo Nordisk Foundation, Novo Holdings A/S, Novo Nordisk A/S, Novozymes A/S and other companies in which the Novo Nordisk Foundation directly or indirectly has a formal or actual controlling interest, as well as employees of the BioInnovation Institute Foundation and the LIFE Foundation, BII Holdings A/S and LIFE A/S and other companies in which the BioInnovation Institute Foundation or the LIFE Foundation directly or indirectly has a formal or actual controlling interest.
b) Members of the Board of Directors of the Novo Nordisk Foundation, the BioInnovation Institute Foundation and the LIFE Foundation, their spouses and children residing in the family home.
c) Members of the Novo Nordisk Foundation’s committees. However, committee members may serve as collaborative partners or advisers on an application. Committee members may also be an applicant or co-applicant on an application submitted to a committee other than the one or ones on which they serve.
d) Applicants who cooperate with or have received grants from the BioInnovation Institute Foundation or the LIFE Foundation are eligible to apply for or receive grants from the Novo Nordisk Foundation, provided that such grants will not be awarded or distributed to the BioInnovation Foundation or the LIFE Foundation.
2. INELIGIBILITY TO ASSESS APPLICATIONS
a) Members of the Board of Directors of the Novo Nordisk Foundation, committees and external assessors (“members”) shall be considered disqualified if a member has a:
ii. professional; or
interest in the outcome of an application: for example, if the member supervises the applicant; is employed in the scientific unit of which the applicant is a leader; or if the member has a family relationship to the applicant. In this context, family relationships are defined as:
i. children, grandchildren, etc.;
ii. parents, brothers, sisters, nieces, nephews, etc.;
iii. grandparents, uncles, aunts, cousins, etc.; and
iv. spouses, partners, cohabitants and their parents, brothers, sisters, children, etc.
b) A member shall be prohibited from participating in assessing any application from an applicant with whom the member has collaborated on research or has co-published a book, scientific article, report or the like within the previous 5 years. Nevertheless, the type and closeness of the collaboration shall determine whether this collaboration is deemed a conflict of interest.
c) A member who is ineligible in relation to an application shall also be ineligible in relation to other applications that compete with the application in question. However, this shall only apply in situations in which the pool of applications amounts to five or less. If a final decision is made on the application or applications to which the member’s ineligibility is linked and this application or these applications are thereby no longer being assessed, the member in question may participate in assessing the remaining applications.
3. PROCEDURE IN CASE OF INELIGIBILITY
a) Members shall notify the chair of the committee and the Novo Nordisk Foundation’s Secretariat of any ineligibility or potential conflict of interest within 10 working days after receiving the applications to be assessed. In case of doubt, the chair of the committee shall consult with representatives of the Novo Nordisk Foundation.
b) If a member has a potential conflict of interest in connection with an application that is to be assessed, the committee shall decide by simple majority whether the conflict of interest disqualifies the member. A member to whom this applies may not participate in assessing the question of ineligibility and shall leave the room during the assessment and voting on the question of ineligibility. In case of a parity of votes, the chair shall hold the casting vote.
c) In cases of ineligibility, members shall be prohibited from participating in assessing an application, including any interviews, and shall leave the room in which the assessment is taking place.
d) If a committee is not quorate or if the composition of a committee and its ability to assess applications may give rise to serious misgivings, the committee shall refer the assessment to the Board of Directors of the Novo Nordisk Foundation.